Inhibrx Biosciences Inc. (INBX) Stock Overview
Explore Inhibrx Biosciences Inc.’s financial performance, market position, analyst ratings, and future outlook.
Inhibrx Biosciences Inc. (INBX)
Key Financials
Key Financials
Market Cap
1.6B
P/E Ratio
-12.22
EPS (TTM)
$-8.88
ROE
18.94%
INBX Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Inhibrx Biosciences Inc. (NASDAQ: INBX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Inhibrx Biosciences Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of INBX on the NASDAQ shows an RSI of 52.15, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $116.07 for the NASDAQ listing.
Key metrics behind Inhibrx Biosciences Inc.'s NASDAQ-traded stock include a P/E ratio of -12.22 and a market capitalization of 1.6B. Combined with our AI analysis, these give both institutional and retail investors a clear view of INBX on the NASDAQ.